P. Matsis

Comparison of the management and in‐hospital outcomes of acute coronary syndrome patients in Australia and New Zealand: results from the binational SNAPSHOT acute coronary syndrome 2012 audit

I. Ranasinghe, H. White, G. Gamble, 2015, Internal medicine journal.

A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012.

H. White, G. Gamble, T. Wang, 2017, The New Zealand medical journal.

Management of patients admitted with an Acute Coronary Syndrome in New Zealand: results of a comprehensive nationwide audit.

H. White, G. Gamble, J. French, 2004, The New Zealand medical journal.

All-Cause Mortality Following an Acute Coronary Syndrome: 12-Year Follow-Up of the Comprehensive 2002 New Zealand Acute Coronary Syndrome Audit.

H. White, G. Gamble, J. French, 2017, Heart, lung & circulation.

Torsades de pointes ventricular tachycardia associated with terfenadine and paracetamol self medication.

R. Easthope, P. Matsis, 1994, The New Zealand medical journal.

Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities.

H. White, G. Gamble, J. French, 2004, The New Zealand medical journal.

Acute lithium toxicity--chorea, hypercalcemia and hyperamylasemia.

R. Fisher, P. Matsis, C. Tasman‐Jones, 1989, Australian and New Zealand journal of medicine.

The management of acute coronary syndrome patients across New Zealand in 2012: results of a third comprehensive nationwide audit and observations of current interventional care.

I. Ranasinghe, H. White, G. Gamble, 2013, The New Zealand medical journal.

Patients admitted with an acute coronary syndrome (ACS) in New Zealand in 2007: results of a second comprehensive nationwide audit and a comparison with the first audit from 2002.

H. White, G. Gamble, C. Ellis, 2010, The New Zealand medical journal.

Management of non ST-elevation acute coronary syndrome patients in New Zealand: a longitudinal analysis. Results from the New Zealand Acute Coronary Syndrome national audits of 2002, 2007 and 2012.

H. White, G. Gamble, J. French, 2016, The New Zealand medical journal.

ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: results of the second comprehensive national audit of ACS patients.

H. White, G. Gamble, C. Ellis, 2010, The New Zealand medical journal.

Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial.

R. Whitbourn, I. Meredith, D. Cutlip, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Pharmacological therapy following acute coronary syndromes in patients with atrial fibrillation: how do we balance ischaemic risk with bleeding risk?

S. Harding, P. Larsen, A. Fake, 2016, The New Zealand medical journal.